Product logins

Find logins to all Clarivate products below.


Blog: Consulting Resource Center

Here you will find relevant articles and insight into all Clarivate related products and news.

Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Commercialization Consulting Resource Center
Key market access considerations for long-acting and alternative delivery therapies Key market access considerations for long-acting and alternative delivery therapies
Blog February 20, 2026
Key market access considerations for long-acting and alternative delivery therapies
Biopharma Commercialization Consulting Resource Center
The market access “sweet spots” where payers reimburse more convenient therapies The market access “sweet spots” where payers reimburse more convenient therapies
Blog February 19, 2026
The market access “sweet spots” where payers reimburse more convenient therapies
Biopharma Commercialization Consulting Resource Center
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization
What healthcare payers reward: adherence versus outcomes What healthcare payers reward: adherence versus outcomes
Blog February 2, 2026
What healthcare payers reward: adherence versus outcomes
Biopharma Consulting Resource Center HMO
Realizing the value of convenience: payer engagement strategies for pharmas Realizing the value of convenience: payer engagement strategies for pharmas
Blog January 21, 2026
Realizing the value of convenience: payer engagement strategies for pharmas
Consulting Resource Center
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot? Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Blog September 25, 2024
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Consulting Resource Center Market Access Pharma
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs
Clinical research Clinical trials Consulting Resource Center

Consulting Resource Center

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Key market access considerations for long-acting and alternative delivery therapies Key market access considerations for long-acting and alternative delivery therapies
Blog February 20, 2026
Key market access considerations for long-acting and alternative delivery therapies
The market access “sweet spots” where payers reimburse more convenient therapies The market access “sweet spots” where payers reimburse more convenient therapies
Blog February 19, 2026
The market access “sweet spots” where payers reimburse more convenient therapies
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
What healthcare payers reward: adherence versus outcomes What healthcare payers reward: adherence versus outcomes
Blog February 2, 2026
What healthcare payers reward: adherence versus outcomes
Realizing the value of convenience: payer engagement strategies for pharmas Realizing the value of convenience: payer engagement strategies for pharmas
Blog January 21, 2026
Realizing the value of convenience: payer engagement strategies for pharmas
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot? Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Blog September 25, 2024
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs
Navigating Joint Clinical Assessment and the role of RWE in the new process Navigating Joint Clinical Assessment and the role of RWE in the new process
Blog March 29, 2024
Navigating Joint Clinical Assessment and the role of RWE in the new process
Pharma R&D productivity dips, but efficiency gains give hope Pharma R&D productivity dips, but efficiency gains give hope
Blog January 23, 2024
Pharma R&D productivity dips, but efficiency gains give hope